Berlin, Charité Medical College, it's nearly midnight.
The lights are still on in Professor Mainshtan's laboratory. He has been stationed there for over a month, with his White Gown wrinkled and his glasses pushed up on his forehead, but the light in his eyes is becoming increasingly bright.
Data is scrolling on the screen in front of him, a complete dataset from twenty-seven research centers globally, involving over four hundred Lynch Syndrome volunteers. This is the familiar path accumulated since Yang Ping's team launched the "New Plan," which is also the largest verification of system regulation theory.
This laboratory plan can confirm that K Therapy is not just capable of treating Tumors; theoretically, it can target a broader range of diseases. This is the most favorable evidence for the system regulation hypothesis.
"Unbelievable..."
